Sarah Ketterer's GSK Position Overview
Sarah Ketterer (via Causeway Capital Management LLC) currently holds 1.18 M shares of GSK plc (GSK) worth $50.8 M, representing 0.67% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Sarah Ketterer has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 230,694 shares. Largest reduction occurred in Q1 2024, reducing 58,256 shares.
Analysis based on 13F filings available since 2013 Q2
Sarah Ketterer's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Sarah Ketterer
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2022 | +206,530 | New Buy | 206,530 | $54.41 |
| Q3 2022 | -22,986 | Reduce 11.13% | 183,544 | $29.43 |
| Q4 2022 | +53,489 | Add 29.14% | 237,033 | $35.14 |
| Q1 2023 | +82,127 | Add 34.65% | 319,160 | $35.58 |
| Q2 2023 | +80,270 | Add 25.15% | 399,430 | $35.64 |
| Q3 2023 | +165,317 | Add 41.39% | 564,747 | $36.25 |
| Q4 2023 | +230,694 | Add 40.85% | 795,441 | $37.06 |
| Q1 2024 | -58,256 | Reduce 7.32% | 737,185 | $42.87 |
| Q2 2024 | +16,350 | Add 2.22% | 753,535 | $38.50 |
| Q3 2024 | +143,871 | Add 19.09% | 897,406 | $40.88 |
| Q4 2024 | +179,174 | Add 19.97% | 1.08 M | $33.82 |
| Q1 2025 | +31,343 | Add 2.91% | 1.11 M | $38.74 |
| Q2 2025 | -847 | Reduce 0.08% | 1.11 M | $38.40 |
| Q3 2025 | +69,925 | Add 6.32% | 1.18 M | $43.16 |
Sarah Ketterer's GSK plc Investment FAQs
Sarah Ketterer first purchased GSK plc (GSK) in Q2 2022, acquiring 206,530 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer has held GSK plc (GSK) for 14 quarters since Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer's largest addition to GSK plc (GSK) was in Q4 2023, adding 795,441 shares worth $29.48 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Sarah Ketterer's firm, Causeway Capital Management LLC, owns 1,177,001 shares of GSK plc (GSK), valued at approximately $50.8 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, GSK plc (GSK) represents approximately 0.67% of Sarah Ketterer's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer's peak holding in GSK plc (GSK) was 1,177,001 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.